Caris Life Sciences Earnings
NASDAQ: CAIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.03
Caris Life Sciences earnings summary
Caris Life Sciences is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.03. In its most recent report on Aug 5, 2026 (Q2 2026), CAI posted EPS of $0.00. Revenue for the quarter was $263.7 million.
Across the last 5 reports, CAI shares moved an average of 6.2% (in either direction) in the first trading session after results, rising 1 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
CAI earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.00 | — | -4.1% |
| May 8, 2026 | — | $0.00 | — | -9.9% |
| Mar 3, 2026 | — | $8.24 | — | -2.4% |
| Nov 5, 2025 | — | $0.08 | — | -6.9% |
| Aug 12, 2025 | — | $-7.97 | — | +7.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.